Viatris Inc

VTRS · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

14 USD

Margin of Safety

-23.2 %

Rating

MEIDEN

Viatris is a globally operating generic and specialty pharmaceutical manufacturer that generates revenues in approximately 165 countries through the marketing of off-patent active ingredients, biosimilars, and a portfolio of established branded pharmaceuticals.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.